Investor Presentation
capitalization
AR
pro-forma share count (in millions, treasury method)
Share Price as of 3/31/2022 (USD):
Subordinate Voting Shares
Multiple Voting Shares
Exchangeable Shares
Warrants (net shares)
Current Ayr Treasury Method Shares (excl. unvested LTIP)¹
Exchangeable Shares for pending M&A²
Treasury Method Shares (pro-forma)¹
$13.25
57.7
3.7
7.7
1.0
70.1
2.5
72.6
pro-forma net debt outstanding
(USD Millions)
Senior Secured Debt (3/31/2022)
Seller Notes and other (3/31/2022)
Seller Notes (pending M&A)²
Total pro-forma Debt
Cash on Balance Sheet (3/31/2022)
Cash to be paid for pending M&A²
Net Debt
1) Excludes impact of contingent consideration; fair value of $133m as of 3/31/2022; 15% payable in cash c.Q2 2023, 55% payable in stock struck March-April 2023; remainder payable debt in 2023
2) Pro-forma for pending M&A transactions as of 3/31/2022 (Herbal Remedies, D33, and Tahoe Hydro); 90% of Seller Notes payable between Q2 2024 and Q1 2025
3) Excludes Ayr granted but unvested LTIP shares totaling 7.7 million
CSE:AYR.A | OTC:AYRWF
$245.2
165.1
19.5
$429.8
$78.7
$16.0
$335.1
19View entire presentation